Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention


  Free Subscription

Articles published in PLoS One

Retrieve available abstracts of 198 articles:
HTML format

Single Articles

    January 2022
  1. FU F, Pietropaolo M, Cui L, Pandit S, et al
    Lack of authentic atrial fibrillation in commonly used murine atrial fibrillation models.
    PLoS One. 2022;17:e0256512.
    PubMed     Abstract available

  2. MOL D, Boersma AM, Berger WR, Khan M, et al
    Intermediate-term outcome of cryoballoon ablation of persistent atrial fibrillation and improvements in quality of life of patients.
    PLoS One. 2022;17:e0261841.
    PubMed     Abstract available

  3. CHRISTERSSON C, Held C, Modica A, Westerbergh J, et al
    Oral anticoagulant treatment after bioprosthetic valvular intervention or valvuloplasty in patients with atrial fibrillation-A SWEDEHEART study.
    PLoS One. 2022;17:e0262580.
    PubMed     Abstract available

  4. REINHART JM, de Oliveira GAR, Forsythe L, Li Z, et al
    Pharmacokinetics of a 503B outsourcing facility-produced theophylline in dogs.
    PLoS One. 2022;17:e0262336.
    PubMed     Abstract available

  5. FASTNER C, Szabo K, Samartzi M, Kruska M, et al
    Treatment standards for direct oral anticoagulants in patients with acute ischemic stroke and non-valvular atrial fibrillation: A survey among German stroke units.
    PLoS One. 2022;17:e0264122.
    PubMed     Abstract available

  6. CHOI BJ, Koo Y, Kim TY, Lim HS, et al
    Data-driven drug-induced QT prolongation surveillance using adverse reaction signals derived from 12-lead and continuous electrocardiogram data.
    PLoS One. 2022;17:e0263117.
    PubMed     Abstract available

  7. LIU X, Liu H, Wang L, Zhang L, et al
    Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0263131.
    PubMed     Abstract available

  8. CIMINATA G, Geue C, Wu O, Deidda M, et al
    Propensity score methods for comparative-effectiveness analysis: A case study of direct oral anticoagulants in the atrial fibrillation population.
    PLoS One. 2022;17:e0262293.
    PubMed     Abstract available

  9. NATHANIA J, Woo BFY, Cher BP, Toh KY, et al
    Patient perspectives of the Self-management and Educational Technology tool for Atrial Fibrillation (SETAF): A mixed-methods study in Singapore.
    PLoS One. 2022;17:e0262033.
    PubMed     Abstract available

  10. SONG J, Zhang Q, Ye L, Zheng Y, et al
    The comparison of catheter ablation on hard outcomes versus medical treatment for atrial fibrillation patients: A meta-analysis of randomized, controlled trials with trial sequential analysis.
    PLoS One. 2022;17:e0262702.
    PubMed     Abstract available

  11. MUNIR MB, Hlavacek P, Keshishian A, Guo JD, et al
    Contemporary clinical and economic outcomes among oral anticoagulant treated and untreated elderly patients with atrial fibrillation: Insights from the United States Medicare database.
    PLoS One. 2022;17:e0263903.
    PubMed     Abstract available

  12. MARTINEZ-CAMPELO L, Cruz R, Blanco-Verea A, Moscoso I, et al
    Searching for genetic modulators of the phenotypic heterogeneity in Brugada syndrome.
    PLoS One. 2022;17:e0263469.
    PubMed     Abstract available

  13. SHABBIR MA, Saad Shaukat MH, Ehtesham M, Murawski S, et al
    Bifascicular block in unexplained syncope is underrecognized and under-evaluated: A single-center audit of ESC guidelines adherence.
    PLoS One. 2022;17:e0263727.
    PubMed     Abstract available

  14. NASIMI F, Yazdchi M
    LDIAED: A lightweight deep learning algorithm implementable on automated external defibrillators.
    PLoS One. 2022;17:e0264405.
    PubMed     Abstract available

  15. RUSS D, Williams JA, Cardoso VR, Bravo-Merodio L, et al
    Evaluating the detection ability of a range of epistasis detection methods on simulated data for pure and impure epistatic models.
    PLoS One. 2022;17:e0263390.
    PubMed     Abstract available

  16. PARK J, Jung JH, Choi EK, Lee SW, et al
    Comparison of early clinical outcomes between dual antiplatelet therapy and triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention.
    PLoS One. 2022;17:e0264538.
    PubMed     Abstract available

  17. IKOMA T, Naruse Y, Kaneko Y, Sakakibara T, et al
    Pre-procedural predictors of left atrial low-voltage zones in patients undergoing catheter ablation of atrial fibrillation.
    PLoS One. 2022;17:e0266939.
    PubMed     Abstract available

  18. OCAK G, Khairoun M, Khairoun O, Bos WJW, et al
    Chronic kidney disease and atrial fibrillation: A dangerous combination.
    PLoS One. 2022;17:e0266046.
    PubMed     Abstract available

  19. HIROSHI I, Natsuko SY, Yutaka I, Masayori S, et al
    Frequency of hemorrhage after tooth extraction in patients treated with a direct oral anticoagulant: A multicenter cross-sectional study.
    PLoS One. 2022;17:e0266011.
    PubMed     Abstract available

  20. MATSUNAGA-LEE Y, Egami Y, Matsumoto S, Masunaga N, et al
    Electrophysiological characteristics of non-pulmonary vein triggers excluding origins from the superior vena cava and left atrial posterior wall: Lessons from the self-reference mapping technique.
    PLoS One. 2022;17:e0263938.
    PubMed     Abstract available

  21. KOGE J, Yamagami H, Toyoda K, Yasaka M, et al
    Early initiation of rivaroxaban after reperfusion therapy for stroke patients with nonvalvular atrial fibrillation.
    PLoS One. 2022;17:e0264760.
    PubMed     Abstract available

  22. ESCOBAR CERVANTES C, Marti-Almor J, Cabeza AIP, Bowrin K, et al
    Real-world cost-effectiveness analysis of NOACs versus VKA for stroke prevention in Spain.
    PLoS One. 2022;17:e0266658.
    PubMed     Abstract available

  23. NAKAI M, Iwanaga Y, Sumita Y, Wada S, et al
    Associations among cardiovascular and cerebrovascular diseases: Analysis of the nationwide claims-based JROAD-DPC dataset.
    PLoS One. 2022;17:e0264390.
    PubMed     Abstract available

  24. SAKAMOTO K, Mukai Y, Kawai S, Nagaoka K, et al
    Intra-atrial activation pattern is useful to localize the areas of non-pulmonary vein triggers of atrial fibrillation.
    PLoS One. 2022;17:e0264894.
    PubMed     Abstract available

  25. UHE T, Stegmann T, Langhammer R, Dagres N, et al
    Signs of left atrial disease and 10-year risk of atrial fibrillation.
    PLoS One. 2022;17:e0266848.
    PubMed     Abstract available

  26. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
    Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
    PLoS One. 2022;17:e0266955.
    PubMed     Abstract available

  27. WEI N, Tolkacheva EG
    Mechanisms of arrhythmia termination during acute myocardial ischemia: Role of ephaptic coupling and complex geometry of border zone.
    PLoS One. 2022;17:e0264570.
    PubMed     Abstract available

  28. ARNOLD R, Hofer E, Haas J, Sanchez-Quintana D, et al
    Diversity and complexity of the cavotricuspid isthmus in rabbits: A novel scheme for classification and geometrical transformation of anatomical structures.
    PLoS One. 2022;17:e0264625.
    PubMed     Abstract available

  29. YAMADA Y, Minatoguchi S, Baba S, Shibata S, et al
    Human Muse cells reduce myocardial infarct size and improve cardiac function without causing arrythmias in a swine model of acute myocardial infarction.
    PLoS One. 2022;17:e0265347.
    PubMed     Abstract available

  30. WATSON GM, Sutherland J, Lacey C, Bridgman PG, et al
    A randomised cross-over trial of QT response to hyperventilation-induced anxiety and diaphragmatic breathing in patients with stress cardiomyopathy and in control patients.
    PLoS One. 2022;17:e0265607.
    PubMed     Abstract available

  31. WANG Y, Han Z, Wang Y, Yan Y, et al
    Risk factors of sitting-induced tachycardia syndrome in children and adolescents.
    PLoS One. 2022;17:e0265364.
    PubMed     Abstract available

  32. ALONSO A, Alam AB, Kamel H, Subbian V, et al
    Epidemiology of atrial fibrillation in the All of Us Research Program.
    PLoS One. 2022;17:e0265498.
    PubMed     Abstract available

  33. SILAND JE, Geelhoed B, Roselli C, Wang B, et al
    Resting heart rate and incident atrial fibrillation: A stratified Mendelian randomization in the AFGen consortium.
    PLoS One. 2022;17:e0268768.
    PubMed     Abstract available

  34. IKEUCHI Y, Ochi H, Motoda C, Tokuyama T, et al
    Plasma MicroRNAs as noninvasive diagnostic biomarkers in patients with Brugada syndrome.
    PLoS One. 2022;17:e0261390.
    PubMed     Abstract available

  35. SENOO K, Yukawa A, Ohkura T, Shoji K, et al
    Screening for untreated atrial fibrillation in the elderly population: A community-based study.
    PLoS One. 2022;17:e0269506.
    PubMed     Abstract available

  36. JANG HJ, Lee D, Kim TH, Kim JS, et al
    Clinical outcomes of gastrointestinal bleeding management during anticoagulation therapy.
    PLoS One. 2022;17:e0269262.
    PubMed     Abstract available

  37. DING M, Li QF, Yin G, Liu JL, et al
    Effects of Drosophila melanogaster regular exercise and apolipoprotein B knockdown on abnormal heart rhythm induced by a high-fat diet.
    PLoS One. 2022;17:e0262471.
    PubMed     Abstract available

  38. SAMUEL JP, Wootton SH, Holder T, Molony D, et al
    A scoping review of randomized trials assessing the impact of n-of-1 trials on clinical outcomes.
    PLoS One. 2022;17:e0269387.
    PubMed     Abstract available

  39. EROGLU TE, Blom MT, Souverein PC, Yasmina A, et al
    Acetylsalicylic acid use is associated with reduced risk of out-of-hospital cardiac arrest in the general population: Real-world data from a population-based study.
    PLoS One. 2022;17:e0267016.
    PubMed     Abstract available

  40. KORNEJ J, Friedrich K, Schroeter ML, Witte AV, et al
    PR interval duration is associated with the presence of white matter hyperintensities: Insights from the epidemiologic LIFE-Adult Study.
    PLoS One. 2022;17:e0269815.
    PubMed     Abstract available

  41. MOON I, Go TH, Kim JY, Kang DR, et al
    Effectiveness and safety of non-vitamin K direct oral anticoagulants in atrial fibrillation patients with bioprosthetic valve.
    PLoS One. 2022;17:e0268113.
    PubMed     Abstract available

  42. ROGERS JD, Higuera L, Rosemas SC, Cheng YJ, et al
    Diagnostic sensitivity and cost per diagnosis of ambulatory cardiac monitoring strategies in unexplained syncope patients.
    PLoS One. 2022;17:e0270398.
    PubMed     Abstract available

  43. FALKENBERG M, Coleman JA, Dobson S, Hickey DJ, et al
    Identifying locations susceptible to micro-anatomical reentry using a spatial network representation of atrial fibre maps.
    PLoS One. 2022;17:e0267166.
    PubMed     Abstract available

  44. DARVISHI A, Sadeghipour P, Darrudi A, Daroudi R, et al
    Cost-utility analysis of Cryoballoon ablation versus Radiofrequency ablation in the treatment of paroxysmal atrial fibrillation in Iran.
    PLoS One. 2022;17:e0270642.
    PubMed     Abstract available

  45. FARRAG NA, Thornhill RE, Prato FS, Skanes AC, et al
    Assessment of left atrial fibrosis progression in canines following rapid ventricular pacing using 3D late gadolinium enhanced CMR images.
    PLoS One. 2022;17:e0269592.
    PubMed     Abstract available

  46. MOKGOKONG R, Schnabel R, Witt H, Miller R, et al
    Performance of an electronic health record-based predictive model to identify patients with atrial fibrillation across countries.
    PLoS One. 2022;17:e0269867.
    PubMed     Abstract available

  47. BOUWMEESTER S, van Loon T, Ploeg M, Mast TP, et al
    Left atrial remodeling in mitral regurgitation: A combined experimental-computational study.
    PLoS One. 2022;17:e0271588.
    PubMed     Abstract available

  48. SU CH, Lo CH, Chen HH, Tsai CF, et al
    CHA2DS2-VASc score as an independent outcome predictor in patients hospitalized with acute ischemic stroke.
    PLoS One. 2022;17:e0270823.
    PubMed     Abstract available

  49. ZHU L, Marsh JW, Griffith MP, Collins K, et al
    Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
    PLoS One. 2022;17:e0271381.
    PubMed     Abstract available

  50. KABUS D, Arno L, Leenknegt L, Panfilov AV, et al
    Numerical methods for the detection of phase defect structures in excitable media.
    PLoS One. 2022;17:e0271351.
    PubMed     Abstract available

  51. NAKAJIMA T, Kawabata-Iwakawa R, Tamura S, Hasegawa H, et al
    Novel CACNA1C R511Q mutation, located in domain - linker, causes non-syndromic type-8 long QT syndrome.
    PLoS One. 2022;17:e0271796.
    PubMed     Abstract available

  52. CHOI JH, Park SJ, Park KM, Kim JS, et al
    Efficacy and safety of cryoballoon pulmonary vein isolation for paroxysmal and persistent atrial fibrillation: A comparison with radiofrequency ablation.
    PLoS One. 2022;17:e0265482.
    PubMed     Abstract available

    January 2021
  53. ZHOU M, Wong CK, Un KC, Lau YM, et al
    Cardiovascular sequalae in uncomplicated COVID-19 survivors.
    PLoS One. 2021;16:e0246732.
    PubMed     Abstract available

  54. KOOK H, Kim HD, Shim J, Kim YH, et al
    Comparison of clinical outcomes between multiple antithrombotic therapy versus left atrial appendage occlusion with dual antiplatelet therapy in patients with atrial fibrillation undergoing drug-eluting stent implantation.
    PLoS One. 2021;16:e0244723.
    PubMed     Abstract available

  55. FINGROVA Z, Ambroz D, Jansa P, Kuchar J, et al
    The prevalence and clinical outcome of supraventricular tachycardia in different etiologies of pulmonary hypertension.
    PLoS One. 2021;16:e0245752.
    PubMed     Abstract available

  56. REZAEI-DARZI E, Mehdipour P, Di Cesare M, Farzadfar F, et al
    Evaluating equality in prescribing Novel Oral Anticoagulants (NOACs) in England: The protocol of a Bayesian small area analysis.
    PLoS One. 2021;16:e0246253.
    PubMed     Abstract available

  57. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
    Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
    PLoS One. 2021;16:e0255263.
    PubMed     Abstract available

  58. SILAND JE, Nguyen BO, de With RR, Van Gelder IC, et al
    Genetically-determined body mass index and the risk of atrial fibrillation progression in men and women.
    PLoS One. 2021;16:e0246907.
    PubMed     Abstract available

  59. SCHMIDT MM, Griffin JM, McCabe P, Stuart-Mullen L, et al
    Shared medical appointments: Translating research into practice for patients treated with ablation therapy for atrial fibrillation.
    PLoS One. 2021;16:e0246861.
    PubMed     Abstract available

  60. QAZI JZ, Schnitzer ME, Cote R, Martel MJ, et al
    Predicting major bleeding among hospitalized patients using oral anticoagulants for atrial fibrillation after discharge.
    PLoS One. 2021;16:e0246691.
    PubMed     Abstract available

  61. XIAOKERETI J, Guo YK, Dong ZY, Ma M, et al
    Enhanced atrial internal-external neural remodeling facilitates atrial fibrillation in the chronic obstructive sleep apnea model.
    PLoS One. 2021;16:e0247308.
    PubMed     Abstract available

  62. SHIYOVICH A, Chodick G, Azani L, Tirosh M, et al
    Sex-specific contemporary trends in incidence, prevalence and survival of patients with non-valvular atrial fibrillation: A long-term real-world data analysis.
    PLoS One. 2021;16:e0247097.
    PubMed     Abstract available

  63. DIMAI S, Semmler L, Prabhu A, Stachelscheid H, et al
    COVID19-associated cardiomyocyte dysfunction, arrhythmias and the effect of Canakinumab.
    PLoS One. 2021;16:e0255976.
    PubMed     Abstract available

  64. CHAU E, Rosella LC, Mondor L, Wodchis WP, et al
    Association between continuity of care and subsequent diagnosis of multimorbidity in Ontario, Canada from 2001-2015: A retrospective cohort study.
    PLoS One. 2021;16:e0245193.
    PubMed     Abstract available

  65. MATUZ A, van der Linden D, Kisander Z, Hernadi I, et al
    Enhanced cardiac vagal tone in mental fatigue: Analysis of heart rate variability in Time-on-Task, recovery, and reactivity.
    PLoS One. 2021;16:e0238670.
    PubMed     Abstract available

  66. CHO SS, Jo SH, Kim HJ, Lee MH, et al
    Smoking may be more harmful to vasospastic angina patients who take antiplatelet agents due to the interaction: Results of Korean prospective multi-center cohort.
    PLoS One. 2021;16:e0248386.
    PubMed     Abstract available

  67. KOZIEL M, Teutsch C, Halperin JL, Rothman KJ, et al
    Atrial fibrillation and comorbidities: Clinical characteristics and antithrombotic treatment in GLORIA-AF.
    PLoS One. 2021;16:e0249524.
    PubMed     Abstract available

  68. LIN YC, Chen BL, Shih CM, Lin FY, et al
    Effectiveness and safety of rivaroxaban versus warfarin in Taiwanese patients with end-stage renal disease and nonvalvular atrial fibrillation: A real-world nationwide cohort study.
    PLoS One. 2021;16:e0249940.
    PubMed     Abstract available

  69. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
    Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
    PLoS One. 2021;16:e0247145.
    PubMed     Abstract available

  70. WENG S, Wang B, Li M, Chao S, et al
    Genome-wide association study of antipsychotic-induced sinus bradycardia in Chinese schizophrenia patients.
    PLoS One. 2021;16:e0249997.
    PubMed     Abstract available

  71. ABAD R, Collart O, Ganesan P, Rogers AJ, et al
    Three dimensional reconstruction to visualize atrial fibrillation activation patterns on curved atrial geometry.
    PLoS One. 2021;16:e0249873.
    PubMed     Abstract available

  72. GOMES FREITAS C, Walsh M, Coutinho EL, Vincenzo de Paola AA, et al
    Examining therapeutic equivalence between branded and generic warfarin in Brazil: The WARFA crossover randomized controlled trial.
    PLoS One. 2021;16:e0248567.
    PubMed     Abstract available

  73. ALAMMARI M, Sultana K, Alturaiki A, Thomas A, et al
    The development and validation of a multivariable model to predict the bleeding risk score for patients with non-valvular atrial fibrillation using direct oral anticoagulants in the Arab population.
    PLoS One. 2021;16:e0250502.
    PubMed     Abstract available

  74. RUFF C, Gerharz A, Groll A, Stoll F, et al
    Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
    PLoS One. 2021;16:e0250298.
    PubMed     Abstract available

  75. HAIDL H, Gaugler J, Cvirn G, Jasser-Nitsche H, et al
    Impact of electric cardioversion on platelet activation.
    PLoS One. 2021;16:e0250353.
    PubMed     Abstract available

  76. DHILLON GS, Ahluwalia N, Honarbakhsh S, Graham A, et al
    Impact of adenosine on mechanisms sustaining persistent atrial fibrillation: Analysis of contact electrograms and non-invasive ECGI mapping data.
    PLoS One. 2021;16:e0248951.
    PubMed     Abstract available

  77. JANG S, Ogunmoroti O, Zhao D, Fashanu OE, et al
    The association of novel inflammatory marker GlycA and incident atrial fibrillation in the Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2021;16:e0248644.
    PubMed     Abstract available

  78. RAVVAZ K, Weissert JA, Jahangir A, Ruff CT, et al
    Evaluating the effects of socioeconomic status on stroke and bleeding risk scores and clinical events in patients on oral anticoagulant for new onset atrial fibrillation.
    PLoS One. 2021;16:e0248134.
    PubMed     Abstract available

  79. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
    Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
    PLoS One. 2021;16:e0248289.
    PubMed     Abstract available

  80. GARCHEVA V, Akin M, Adel J, Sanchez Martinez C, et al
    High rate of critical coronary stenosis in comatose patients with Non-ST-elevation out-of-hospital cardiac arrest (NSTE-OHCA) undergoing therapeutic hypothermia-Experience from the HAnnover COoling REgistry (HACORE).
    PLoS One. 2021;16:e0251178.
    PubMed     Abstract available

  81. YANASE T, Sakakura K, Jinnouchi H, Taniguchi Y, et al
    Factors associated with temporary pacing insertion in patients with inferior ST-segment elevation myocardial infarction.
    PLoS One. 2021;16:e0251124.
    PubMed     Abstract available

  82. ZAGIDULLIN NS, Motloch LJ, Musin TI, Bagmanova ZA, et al
    J-waves in acute COVID-19: A novel disease characteristic and predictor of mortality?
    PLoS One. 2021;16:e0257982.
    PubMed     Abstract available

  83. GUO A, Smith S, Khan YM, Langabeer Ii JR, et al
    Application of a time-series deep learning model to predict cardiac dysrhythmias in electronic health records.
    PLoS One. 2021;16:e0239007.
    PubMed     Abstract available

  84. SYOMIN F, Osepyan A, Tsaturyan A
    Computationally efficient model of myocardial electromechanics for multiscale simulations.
    PLoS One. 2021;16:e0255027.
    PubMed     Abstract available

  85. MASJEDI M, Jungen C, Kuklik P, Alken FA, et al
    A novel algorithm for 3-D visualization of electrogram duration for substrate-mapping in patients with ischemic heart disease and ventricular tachycardia.
    PLoS One. 2021;16:e0254683.
    PubMed     Abstract available

  86. REICHMANN-ARIEL D, Sadeh R, Galante O, Almog Y, et al
    Central venous catheter insertion- guidewire migration ratio: Right heart to inferior vena cava.
    PLoS One. 2021;16:e0252726.
    PubMed     Abstract available

  87. NASCIUTTI PR, Moraes AT, Santos TK, Goncalves Queiroz KK, et al
    Protective effects of omega-3 fatty acids in dogs with myxomatous mitral valve disease stages B2 and C.
    PLoS One. 2021;16:e0254887.
    PubMed     Abstract available

  88. ROSENSTROM S, Risom SS, Ejlertsen C, Hove JD, et al
    Dancing with atrial fibrillation - How arrhythmia affects everyday life of family members: A qualitative study.
    PLoS One. 2021;16:e0254130.
    PubMed     Abstract available

  89. LIU XH, Xu Q, Luo T, Zhang L, et al
    Discontinuation of oral anticoagulation therapy after successful atrial fibrillation ablation: A systematic review and meta-analysis of prospective studies.
    PLoS One. 2021;16:e0253709.
    PubMed     Abstract available

  90. MALLADI CL, Darden D, Aldaas O, Mylavarapu PS, et al
    Association between specific antiarrhythmic drug prescription in the post-procedural blanking period and recurrent atrial arrhythmias after catheter ablation for atrial fibrillation.
    PLoS One. 2021;16:e0253266.
    PubMed     Abstract available

  91. SLAUGHTER MS, Monreal G, Koenig SC, Giridharan GA, et al
    Demonstration of proof-of-concept of StrokeShield system for complete closure and occlusion of the left atrial appendage for non-valvular atrial fibrillation therapy.
    PLoS One. 2021;16:e0253299.
    PubMed     Abstract available

  92. LEE HJ, Kim HK, Kim BS, Han KD, et al
    Risk of upper gastrointestinal bleeding in patients on oral anticoagulant and proton pump inhibitor co-therapy.
    PLoS One. 2021;16:e0253310.
    PubMed     Abstract available

  93. WEFERLING M, Liebetrau C, Renker M, Fischer-Rasokat U, et al
    Right bundle branch block is not associated with worse short- and mid-term outcome after transcatheter aortic valve implantation.
    PLoS One. 2021;16:e0253332.
    PubMed     Abstract available

  94. HAMMER KP, Mustroph J, Stauber T, Birchmeier W, et al
    Beneficial effect of voluntary physical exercise in Plakophilin2 transgenic mice.
    PLoS One. 2021;16:e0252649.
    PubMed     Abstract available

  95. MISGANAW A, Sitote M, Jemal S, Melese E, et al
    Comparison of intravenous magnesium sulphate and lidocaine for attenuation of cardiovascular response to laryngoscopy and endotracheal intubation in elective surgical patients at Zewditu Memorial Hospital Addis Ababa, Ethiopia.
    PLoS One. 2021;16:e0252465.
    PubMed     Abstract available

  96. PALACIO LC, Pachajoa DC, Durango-Giraldo G, Zapata-Hernandez C, et al
    Atrial proarrhythmic effect of lead as one of the PM10 metal components of air pollution. An in-silico study.
    PLoS One. 2021;16:e0258313.
    PubMed     Abstract available

  97. KIM BJ, Lee KJ, Park EL, Tanaka K, et al
    Prediction of recurrent stroke among ischemic stroke patients with atrial fibrillation: Development and validation of a risk score model.
    PLoS One. 2021;16:e0258377.
    PubMed     Abstract available

  98. LANGE M, Hirahara AM, Ranjan R, Stoddard GJ, et al
    Atrial slow conduction develops and dynamically expands during premature stimulation in an animal model of persistent atrial fibrillation.
    PLoS One. 2021;16:e0258285.
    PubMed     Abstract available

  99. STEINHUBL SR, Waalen J, Sanyal A, Edwards AM, et al
    Three year clinical outcomes in a nationwide, observational, siteless clinical trial of atrial fibrillation screening-mHealth Screening to Prevent Strokes (mSToPS).
    PLoS One. 2021;16:e0258276.
    PubMed     Abstract available

  100. NIJPELS G, van der Heijden AAWA, Elders P, Beulens JWJ, et al
    The interobserver agreement of ECG abnormalities using Minnesota codes in people with type 2 diabetes.
    PLoS One. 2021;16:e0255466.
    PubMed     Abstract available

  101. CHO JH, Leong D, Cuk N, Ebinger JE, et al
    Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
    PLoS One. 2021;16:e0254641.
    PubMed     Abstract available

  102. GARCIA-VILLAFRANCA A, Barrera-Lopez L, Pose-Bar M, Pardellas-Santiago E, et al
    De-novo non-convulsive status epilepticus in adult medical inpatients without known epilepsy: Analysis of mortality related factors and literature review.
    PLoS One. 2021;16:e0258602.
    PubMed     Abstract available

  103. PIAYDA K, Afzal S, Nielsen-Kudsk JE, Schmidt B, et al
    Length of stay following percutaneous left atrial appendage occlusion: Data from the prospective, multicenter Amplatzer Amulet Occluder Observational Study.
    PLoS One. 2021;16:e0255721.
    PubMed     Abstract available

  104. RIVOLO S, Di Fusco M, Polanco C, Kang A, et al
    Cost-effectiveness analysis of apixaban versus vitamin K antagonists for antithrombotic therapy in patients with atrial fibrillation after acute coronary syndrome or percutaneous coronary intervention in Spain.
    PLoS One. 2021;16:e0259251.
    PubMed     Abstract available

  105. QIAN Y, Zhang J, Li J, Weng Z, et al
    A retrospective study on the evaluation of the appropriateness of oral anticoagulant therapy for patients with atrial fibrillation.
    PLoS One. 2021;16:e0259199.
    PubMed     Abstract available

  106. NEUBER JU, Pakhomov AG, Zemlin CW
    Electroporation safety factor of 300 nanosecond and 10 millisecond defibrillation in Langendorff-perfused rabbit hearts.
    PLoS One. 2021;16:e0257287.
    PubMed     Abstract available

  107. CANNAVAN PMS, Cannavan FPS, Oliveira HC, Walfridsson U, et al
    A Brazilian Portuguese translation, cultural adaptation and validation of the Arrhythmia-Specific questionnaire in Tachycardia and Arrhythmia (ASTA) health-related quality of life (HRQOL) scale.
    PLoS One. 2021;16:e0256851.
    PubMed     Abstract available

  108. XIAO J, Zhang Y, Tang Y, Dai H, et al
    MiRNA-1202 promotes the TGF-beta1-induced proliferation, differentiation and collagen production of cardiac fibroblasts by targeting nNOS.
    PLoS One. 2021;16:e0256066.
    PubMed     Abstract available

  109. REINHARDT SW, Desai NR, Tang Y, Jones PG, et al
    Personalizing the decision of dabigatran versus warfarin in atrial fibrillation: A secondary analysis of the Randomized Evaluation of Long-term anticoagulation therapY (RE-LY) trial.
    PLoS One. 2021;16:e0256338.
    PubMed     Abstract available

  110. LANKESTER J, Zanetti D, Ingelsson E, Assimes TL, et al
    Alcohol use and cardiometabolic risk in the UK Biobank: A Mendelian randomization study.
    PLoS One. 2021;16:e0255801.
    PubMed     Abstract available

  111. KIM IS, Choi YJ, Choi EY, Min PK, et al
    Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
    PLoS One. 2021;16:e0258770.
    PubMed     Abstract available

  112. BAHRAMI RAD A, Galloway C, Treiman D, Xue J, et al
    Atrial fibrillation detection in outpatient electrocardiogram monitoring: An algorithmic crowdsourcing approach.
    PLoS One. 2021;16:e0259916.
    PubMed     Abstract available

  113. NAM KW, Kwon HM, Lee YS
    Effects of intracranial atherosclerosis and atrial fibrillation on the prognosis of ischemic stroke with active cancer.
    PLoS One. 2021;16:e0259627.
    PubMed     Abstract available

  114. WATANABE K, Nagata Y, Nitta G, Okata S, et al
    Impact of the sinus node recovery time after termination of atrial fibrillation during catheter ablation on clinical outcomes in patients with persistent atrial fibrillation.
    PLoS One. 2021;16:e0259750.
    PubMed     Abstract available

  115. YANAGISAWA D, Abe K, Amano H, Komatsuda S, et al
    Thrombotic events and rebleeding after hemorrhage in patients taking direct oral anticoagulants for non-valvular atrial fibrillation.
    PLoS One. 2021;16:e0260585.
    PubMed     Abstract available

  116. STRUPPEK J, Schnabel RB, Walther C, Heydecke G, et al
    Periodontitis, dental plaque, and atrial fibrillation in the Hamburg City Health Study.
    PLoS One. 2021;16:e0259652.
    PubMed     Abstract available

  117. MOTOC A, Luchian ML, Scheirlynck E, Roosens B, et al
    Incremental value of left atrial strain to predict atrial fibrillation recurrence after cryoballoon ablation.
    PLoS One. 2021;16:e0259999.
    PubMed     Abstract available

  118. SUBA S, Fleischmann KE, Schell-Chaple H, Prasad P, et al
    Diagnostic and prognostic significance of premature ventricular complexes in community and hospital-based participants: A scoping review.
    PLoS One. 2021;16:e0261712.
    PubMed     Abstract available

  119. SAGER S, Bernhardt F, Kehrle F, Merkert M, et al
    Expert-enhanced machine learning for cardiac arrhythmia classification.
    PLoS One. 2021;16:e0261571.
    PubMed     Abstract available

  120. YOSHIKAWA M, Asaba K, Nakayama T
    Causal effect of atrial fibrillation/flutter on chronic kidney disease: A bidirectional two-sample Mendelian randomization study.
    PLoS One. 2021;16:e0261020.
    PubMed     Abstract available

  121. LIU HT, Yang CH, Lee HL, Chang PC, et al
    Clinical Outcomes of low-voltage area-guided left atrial linear ablation for non-paroxysmal atrial fibrillation patients.
    PLoS One. 2021;16:e0260834.
    PubMed     Abstract available

  122. JANG JH, Kim TY, Lim HS, Yoon D, et al
    Unsupervised feature learning for electrocardiogram data using the convolutional variational autoencoder.
    PLoS One. 2021;16:e0260612.
    PubMed     Abstract available

  123. PATON MF, Gierula J, Lowry JE, Cairns DA, et al
    Personalised reprogramming to prevent progressive pacemaker-related left ventricular dysfunction: A phase II randomised, controlled clinical trial.
    PLoS One. 2021;16:e0259450.
    PubMed     Abstract available

  124. ANDERSON K, Bavishi C, Kolte D, Gohh R, et al
    Relation of abnormal cardiac stress testing with outcomes in patients undergoing renal transplantation.
    PLoS One. 2021;16:e0260718.
    PubMed     Abstract available

    January 2020
  125. BOWRIN K, Briere JB, Fauchier L, Coleman C, et al
    Real-world cost-effectiveness of rivaroxaban compared with vitamin K antagonists in the context of stroke prevention in atrial fibrillation in France.
    PLoS One. 2020;15:e0225301.
    PubMed     Abstract available

  126. MCALISTER FA, Mian R, Oldgren J, Wallentin L, et al
    Hypertension prevalence but not control varies across the spectrum of risk in patients with atrial fibrillation: A RE-LY atrial fibrillation registry sub-study.
    PLoS One. 2020;15:e0226259.
    PubMed     Abstract available

  127. CHANG NC, Hu P, Chen TH, Mao CT, et al
    Drug-eluting versus bare-metal stents for first myocardial infarction in patients with atrial fibrillation: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227571.
    PubMed     Abstract available

  128. SEMAKULA JR, Mouton JP, Jorgensen A, Hutchinson C, et al
    A cross-sectional evaluation of five warfarin anticoagulation services in Uganda and South Africa.
    PLoS One. 2020;15:e0227458.
    PubMed     Abstract available

  129. KIM T, Kim KS, Suh GJ, Kwon WY, et al
    Duty cycle of 33% increases cardiac output during cardiopulmonary resuscitation.
    PLoS One. 2020;15:e0228111.
    PubMed     Abstract available

  130. HSIEH HL, Hsu SC, Cheng HS, Chen CY, et al
    The influence of atrial fibrillation on the mortality of incident ESRD patients undergoing maintenance hemodialysis.
    PLoS One. 2020;15:e0228405.
    PubMed     Abstract available

  131. WALEK P, Sielski J, Gorczyca I, Roskal-Walek J, et al
    Left atrial mechanical remodelling assessed as the velocity of left atrium appendage wall motion during atrial fibrillation is associated with maintenance of sinus rhythm after electrical cardioversion in patients with persistent atrial fibrillation.
    PLoS One. 2020;15:e0228239.
    PubMed     Abstract available

  132. MOON I, Lee SY, Kim HK, Han KD, et al
    Trends of the prevalence and incidence of hypertrophic cardiomyopathy in Korea: A nationwide population-based cohort study.
    PLoS One. 2020;15:e0227012.
    PubMed     Abstract available

  133. MOUSAVI S, Fotoohinasab A, Afghah F
    Single-modal and multi-modal false arrhythmia alarm reduction using attention-based convolutional and recurrent neural networks.
    PLoS One. 2020;15:e0226990.
    PubMed     Abstract available

  134. HSIEH YC, Hsieh WH, Li CH, Liao YC, et al
    Ventricular divergence correlates with epicardial wavebreaks and predicts ventricular arrhythmia in isolated rabbit hearts during therapeutic hypothermia.
    PLoS One. 2020;15:e0228818.
    PubMed     Abstract available

  135. FARRAHA M, Lu J, Trivic I, Barry MA, et al
    Development of a sheep model of atrioventricular block for the application of novel therapies.
    PLoS One. 2020;15:e0229092.
    PubMed     Abstract available

  136. GLINGE C, Engstrom T, Midgley SE, Tanck MWT, et al
    Seasonality of ventricular fibrillation at first myocardial infarction and association with viral exposure.
    PLoS One. 2020;15:e0226936.
    PubMed     Abstract available

  137. ZHAO H, Liu M, Chen Z, Mei K, et al
    Dose-response analysis between hemoglobin A1c and risk of atrial fibrillation in patients with and without known diabetes.
    PLoS One. 2020;15:e0227262.
    PubMed     Abstract available

  138. LOWN M, Brown M, Brown C, Yue AM, et al
    Machine learning detection of Atrial Fibrillation using wearable technology.
    PLoS One. 2020;15:e0227401.
    PubMed     Abstract available

  139. STOCKIGT F, Eichhorn L, Beiert T, Knappe V, et al
    Heart failure after pressure overload in autosomal-dominant desminopathies: Lessons from heterozygous DES-p.R349P knock-in mice.
    PLoS One. 2020;15:e0228913.
    PubMed     Abstract available

  140. ROMERO D, Behar N, Petit B, Probst V, et al
    Dynamic changes in ventricular depolarization during exercise in patients with Brugada syndrome.
    PLoS One. 2020;15:e0229078.
    PubMed     Abstract available

  141. ZHANG C, Gao J, Guo Y, Xing A, et al
    Association of atrial fibrillation and clinical outcomes in adults with chronic kidney disease: A propensity score-matched analysis.
    PLoS One. 2020;15:e0230189.
    PubMed     Abstract available

  142. ZIMIK S, Pandit R, Majumder R
    Anisotropic shortening in the wavelength of electrical waves promotes onset of electrical turbulence in cardiac tissue: An in silico study.
    PLoS One. 2020;15:e0230214.
    PubMed     Abstract available

  143. SHINGU Y, Takada S, Yokota T, Shirakawa R, et al
    Correlation between increased atrial expression of genes related to fatty acid metabolism and autophagy in patients with chronic atrial fibrillation.
    PLoS One. 2020;15:e0224713.
    PubMed     Abstract available

  144. MARCHENA M, Echebarria B
    Influence of the tubular network on the characteristics of calcium transients in cardiac myocytes.
    PLoS One. 2020;15:e0231056.
    PubMed     Abstract available

  145. KUBITZ JC, Schulte-Uentrop L, Zoellner C, Lemke M, et al
    Establishment of an enhanced recovery after surgery protocol in minimally invasive heart valve surgery.
    PLoS One. 2020;15:e0231378.
    PubMed     Abstract available

  146. MANDALA S, Cai Di T, Sunar MS, Adiwijaya, et al
    ECG-based prediction algorithm for imminent malignant ventricular arrhythmias using decision tree.
    PLoS One. 2020;15:e0231635.
    PubMed     Abstract available

  147. KOWALEWSKI M, Jasinski M, Staromlynski J, Zembala M, et al
    On-Pump vs Off-Pump coronary artery bypass surgery in atrial fibrillation. Analysis from the polish national registry of cardiac surgery procedures (KROK).
    PLoS One. 2020;15:e0231950.
    PubMed     Abstract available

  148. YAN J, Li H, Bu H, Jiao K, et al
    Aging-associated sinus arrest and sick sinus syndrome in adult zebrafish.
    PLoS One. 2020;15:e0232457.
    PubMed     Abstract available

  149. LARUPA SANTOS J, Rodriguez I, S Olesen M, Hjorth Bentzen B, et al
    Investigating gene-microRNA networks in atrial fibrillation patients with mitral valve regurgitation.
    PLoS One. 2020;15:e0232719.
    PubMed     Abstract available

  150. PRITCHETT RV, Clarke JL, Jolly K, Clarkesmith D, et al
    Clinicians' views and experiences of prescribing oral anticoagulants for stroke prevention in atrial fibrillation: A qualitative meta-synthesis.
    PLoS One. 2020;15:e0232484.
    PubMed     Abstract available

  151. CLAUSS S, Schuttler D, Bleyer C, Vlcek J, et al
    Characterization of a porcine model of atrial arrhythmogenicity in the context of ischaemic heart failure.
    PLoS One. 2020;15:e0232374.
    PubMed     Abstract available

  152. CHIOU YA, Cheng LK, Lin SF
    Effects of high-frequency biphasic shocks on ventricular vulnerability and defibrillation outcomes through synchronized virtual electrode responses.
    PLoS One. 2020;15:e0232529.
    PubMed     Abstract available

  153. CHUN KJ, Gwag HB, Hwang JK, Park SJ, et al
    Is transjugular insertion of a temporary pacemaker a safe and effective approach?
    PLoS One. 2020;15:e0233129.
    PubMed     Abstract available

  154. ESCOBAR C, Borras X, Bover Freire R, Gonzalez-Juanatey C, et al
    A Delphi consensus on the management of oral anticoagulation in patients with non-valvular atrial fibrillation in Spain: ACOPREFERENCE study.
    PLoS One. 2020;15:e0231565.
    PubMed     Abstract available

  155. SWANSON KM, Zhu Y, Rojas RL, St Sauver JL, et al
    Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort.
    PLoS One. 2020;15:e0233316.
    PubMed     Abstract available

  156. SHAWER H, Aiyelaagbe E, Clowes C, Lean SC, et al
    A missense mutation of ErbB2 produces a novel mouse model of stillbirth associated with a cardiac abnormality but lacking abnormalities of placental structure.
    PLoS One. 2020;15:e0233007.
    PubMed     Abstract available

  157. ANWAR O, Gunawardene MA, Dickow J, Scherschel K, et al
    Contemporary analysis of phrenic nerve injuries following cryoballoon-based pulmonary vein isolation: A single-centre experience with the systematic use of compound motor action potential monitoring.
    PLoS One. 2020;15:e0235132.
    PubMed     Abstract available

  158. DE ROSA S, Sabatino J, Polimeni A, Sorrentino S, et al
    Dual anti-thrombotic treatment with direct anticoagulants improves clinical outcomes in patients with Atrial Fibrillation with ACS or undergoing PCI. A systematic review and meta-analysis.
    PLoS One. 2020;15:e0235511.
    PubMed     Abstract available

  159. TSAI BM, Sun JT, Hsieh MJ, Lin YY, et al
    Optimal paramedic numbers in resuscitation of patients with out-of-hospital cardiac arrest: A randomized controlled study in a simulation setting.
    PLoS One. 2020;15:e0235315.
    PubMed     Abstract available

  160. ZAPOLSKI T, Kaminska A, Kocki T, Wysokinski A, et al
    Aortic stiffness-Is kynurenic acid a novel marker? Cross-sectional study in patients with persistent atrial fibrillation.
    PLoS One. 2020;15:e0236413.
    PubMed     Abstract available

  161. JILLELLA DV, Janocko NJ, Nahab F, Benameur K, et al
    Ischemic stroke in COVID-19: An urgent need for early identification and management.
    PLoS One. 2020;15:e0239443.
    PubMed     Abstract available

  162. ALAHMADI A, Davies A, Vigo M, Jay C, et al
    Pseudo-colouring an ECG enables lay people to detect QT-interval prolongation regardless of heart rate.
    PLoS One. 2020;15:e0237854.
    PubMed     Abstract available

  163. VAZE A, Tran KV, Tanriverdi K, Sardana M, et al
    Relations between plasma microRNAs, echocardiographic markers of atrial remodeling, and atrial fibrillation: Data from the Framingham Offspring study.
    PLoS One. 2020;15:e0236960.
    PubMed     Abstract available

  164. MOMO K, Shu-Toh K, Kaneko M, Yamanaka N, et al
    Predictive factors associated with bleeding in atrial fibrillation patients treated with anti-coagulant drugs using a large claims database.
    PLoS One. 2020;15:e0238233.
    PubMed     Abstract available

  165. BUCHHORN R, Baumann C, Gundogdu S, Rakowski U, et al
    Diagnosis and management of an inappropriate sinus tachycardia in adolescence based upon a Holter ECG: A retrospective analysis of 479 patients.
    PLoS One. 2020;15:e0238139.
    PubMed     Abstract available

  166. WALEK P, Gorczyca I, Sielski J, Wozakowska-Kaplon B, et al
    Left atrial emptying fraction determined during atrial fibrillation predicts maintenance of sinus rhythm after direct current cardioversion in patients with persistent atrial fibrillation.
    PLoS One. 2020;15:e0238002.
    PubMed     Abstract available

  167. ROSE P, Schleimer JH, Schreiber S
    Modifications of sodium channel voltage dependence induce arrhythmia-favouring dynamics of cardiac action potentials.
    PLoS One. 2020;15:e0236949.
    PubMed     Abstract available

  168. UMEMURA T, Mashita S, Kawamura T
    Oral anticoagulant use and the development of new cerebral microbleeds in cardioembolic stroke patients with atrial fibrillation.
    PLoS One. 2020;15:e0238456.
    PubMed     Abstract available

  169. JAAKKOLA J, Jaakkola S, Airaksinen KEJ, Husso A, et al
    Subtype of atrial fibrillation and the outcome of transcatheter aortic valve replacement: The FinnValve Study.
    PLoS One. 2020;15:e0238953.
    PubMed     Abstract available

  170. ZAMUDIO GS, Marquez MF, Jose MV
    Anticipation of ventricular tachyarrhythmias by a novel mathematical method: Further insights towards an early warning system in implantable cardioverter defibrillators.
    PLoS One. 2020;15:e0235101.
    PubMed     Abstract available

  171. NAKATA T, Doi A, Uta D, Yoshimura M, et al
    Excessive exercise induces cardiac arrhythmia in a young fibromyalgia mouse model.
    PLoS One. 2020;15:e0239473.
    PubMed     Abstract available

  172. MOSAYEBI A, Mojaradi B, Bonyadi Naeini A, Khodadad Hosseini SH, et al
    Modeling and comparing data mining algorithms for prediction of recurrence of breast cancer.
    PLoS One. 2020;15:e0237658.
    PubMed     Abstract available

  173. KIM YG, Shim J, Boo KY, Kim DY, et al
    Slit-based irrigation catheters can reduce procedure-related ischemic stroke in atrial fibrillation patients undergoing radiofrequency catheter ablation.
    PLoS One. 2020;15:e0239339.
    PubMed     Abstract available

  174. WAN H, Selvaggio G, Pearlstein RA
    Toward in vivo-relevant hERG safety assessment and mitigation strategies based on relationships between non-equilibrium blocker binding, three-dimensional channel-blocker interactions, dynamic occupancy, dynamic exposure, and cellular arrhythmia.
    PLoS One. 2020;15:e0234946.
    PubMed     Abstract available

  175. PARK J, Choi EK, Han KD, Kim B, et al
    Outcomes in relation to antithrombotic therapy among patients with atrial fibrillation after percutaneous coronary intervention.
    PLoS One. 2020;15:e0240161.
    PubMed     Abstract available

  176. PATEL H, DiDomenico RJ, Suda KJ, Schumock GT, et al
    Risk of cardiac events with azithromycin-A prediction model.
    PLoS One. 2020;15:e0240379.
    PubMed     Abstract available

  177. MIYOSAWA K, Iwata H, Minami-Takano A, Hayashi H, et al
    Enhanced monocyte migratory activity in the pathogenesis of structural remodeling in atrial fibrillation.
    PLoS One. 2020;15:e0240540.
    PubMed     Abstract available

  178. CHO HJ, Kang YJ, Sung SM, Ahn SH, et al
    Effects of dabigatran and rivaroxaban on stroke severity according to the results of routine coagulation tests.
    PLoS One. 2020;15:e0240483.
    PubMed     Abstract available

  179. EVANS A, Davies M, Osborne V, Roy D, et al
    Incidence of major and clinically relevant non-major bleeding in patients prescribed rivaroxaban for stroke prevention in non-valvular atrial fibrillation in secondary care: Results from the Rivaroxaban Observational Safety Evaluation (ROSE) study.
    PLoS One. 2020;15:e0240489.
    PubMed     Abstract available

  180. SPRINGER A, Monsch AU, Dutilh G, Coslovsky M, et al
    A factor score reflecting cognitive functioning in patients from the Swiss Atrial Fibrillation Cohort Study (Swiss-AF).
    PLoS One. 2020;15:e0240167.
    PubMed     Abstract available

  181. GUNASEKARAN T, Olivier B, Griffith L, Sanders R, et al
    Comparison of heart rate obtained from shorter duration Holter recordings to 24-hour mean heart rate in dogs with atrial fibrillation.
    PLoS One. 2020;15:e0241620.
    PubMed     Abstract available

  182. KAWAJI T, Shizuta S, Aizawa T, Yamagami S, et al
    Renal function and outcomes in atrial fibrillation patients after catheter ablation.
    PLoS One. 2020;15:e0241449.
    PubMed     Abstract available

  183. MIZOKAMI Y, Yamamoto T, Atarashi H, Yamashita T, et al
    Current status of proton pump inhibitor use in Japanese elderly patients with non-valvular atrial fibrillation: A subanalysis of the ANAFIE Registry.
    PLoS One. 2020;15:e0240859.
    PubMed     Abstract available

  184. MATANGILA JR, Nyembu RK, Telo GM, Ngoy CD, et al
    Clinical characteristics of COVID-19 patients hospitalized at Clinique Ngaliema, a public hospital in Kinshasa, in the Democratic Republic of Congo: A retrospective cohort study.
    PLoS One. 2020;15:e0244272.
    PubMed     Abstract available

  185. BANG OY, On YK, Lee MY, Jang SW, et al
    The risk of stroke/systemic embolism and major bleeding in Asian patients with non-valvular atrial fibrillation treated with non-vitamin K oral anticoagulants compared to warfarin: Results from a real-world data analysis.
    PLoS One. 2020;15:e0242922.
    PubMed     Abstract available

  186. ROH SY, Choi JI, Kim MS, Cho EY, et al
    Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
    PLoS One. 2020;15:e0242799.
    PubMed     Abstract available

  187. DI DIEGO JM, Patocskai B, Barajas-Martinez H, Borbath V, et al
    Acacetin suppresses the electrocardiographic and arrhythmic manifestations of the J wave syndromes.
    PLoS One. 2020;15:e0242747.
    PubMed     Abstract available

  188. CHO JH, Namazi A, Shelton R, Ramireddy A, et al
    Cardiac arrhythmias in hospitalized patients with COVID-19: A prospective observational study in the western United States.
    PLoS One. 2020;15:e0244533.
    PubMed     Abstract available

  189. SEO C, Michie C, Hibbert B, Davis DR, et al
    Systematic review of pre-clinical therapies for post-operative atrial fibrillation.
    PLoS One. 2020;15:e0241643.
    PubMed     Abstract available

  190. KAZMI SZH, Habib N, Riaz R, Rizvi SS, et al
    Multiscale based nonlinear dynamics analysis of heart rate variability signals.
    PLoS One. 2020;15:e0243441.
    PubMed     Abstract available

  191. KOPONEN M, Marjamaa A, Tuiskula AM, Viitasalo M, et al
    Genealogy and clinical course of catecholaminergic polymorphic ventricular tachycardia caused by the ryanodine receptor type 2 P2328S mutation.
    PLoS One. 2020;15:e0243649.
    PubMed     Abstract available

  192. RIEG T, Frick J, Baumgartl H, Buettner R, et al
    Demonstration of the potential of white-box machine learning approaches to gain insights from cardiovascular disease electrocardiograms.
    PLoS One. 2020;15:e0243615.
    PubMed     Abstract available

  193. WU VC, Wang CL, Gan ST, Wu M, et al
    Efficacy and safety of NOAC versus warfarin in AF patients with left atrial enlargement.
    PLoS One. 2020;15:e0243866.
    PubMed     Abstract available

  194. SUZUKI A, Okamura T, Sasaki M, Matsuoka H, et al
    Acceleration of opportunistic atrial fibrillation screening for elderly patients in routine primary care.
    PLoS One. 2020;15:e0244240.
    PubMed     Abstract available

    January 2019
  195. YOU CH, Lin CK, Chen PH, Park S, et al
    Clarithromycin use and the risk of mortality and cardiovascular events: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0226637.
    PubMed     Abstract available

  196. DIETL A, Winkel I, Pietrzyk G, Paulus M, et al
    Skeletal muscle alterations in tachycardia-induced heart failure are linked to deficient natriuretic peptide signalling and are attenuated by RAS-/NEP-inhibition.
    PLoS One. 2019;14:e0225937.
    PubMed     Abstract available

  197. SHAKIBFAR S, Krause O, Lund-Andersen C, Strycko F, et al
    Impact of device programming on the success of the first anti-tachycardia pacing therapy: An anonymized large-scale study.
    PLoS One. 2019;14:e0219533.
    PubMed     Abstract available

  198. WITASSEK F, Springer A, Adam L, Aeschbacher S, et al
    Health-related quality of life in patients with atrial fibrillation: The role of symptoms, comorbidities, and the type of atrial fibrillation.
    PLoS One. 2019;14:e0226730.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Arrhythmias is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.